DRD4 and attention deficit-hyperactivity disorder: DRD4 and α2AR co-localize in cortical pyramidal neurons to form α2AR-D4R heteromers which play a pivotal role in catecholaminergic signaling in the brain cortex and are potential targets for ADHD pharmacotherapy (Casadó-Anguera et al., 2021).